Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Medtronic
Dow
Colorcon
McKinsey

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Cortisone acetate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for cortisone acetate and what is the scope of patent protection?

Cortisone acetate is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn, Watson Labs, Merck, Barr, Elkins Sinn, Everylife, Heather, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Lannett, Panray, Purepac Pharm, Vitarine, and Whiteworth Town Plsn, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy-nine drug master file entries for cortisone acetate. One supplier is listed for this compound.

Recent Clinical Trials for cortisone acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 2/Phase 3
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all cortisone acetate clinical trials

Pharmacology for cortisone acetate
Medical Subject Heading (MeSH) Categories for cortisone acetate
Synonyms for cortisone acetate
[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
003C609
11-Dehydro-17-hydroxycorticosterone acetate
11-Dehydro-17-hydroxycorticosterone-21-acetate
17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate
17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate #
17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-acetate
17,21-Dihydroxypregn-4-ene-3,11,20-trione-21-acetate
17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione 21-acetate
17alpha,21-dihydroxypregn-4-ene-3,11,20-trione acetate
2-((1S,10S,11S,15S,2R,14R)-14-hydroxy-2,15-dimethyl-5,17-dioxotetracyclo[8.7.0 .0<2,7>.0<11,15>]heptadec-6-en-14-yl)-2-oxoethyl acetate
2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
21-(Acetyloxy)-17-hydroxypregn-4-ene-3,11,20-trione
21-Acetoxy-17,alpha-hydroxy-3,11,20-triketopregnene-4
21-Acetoxy-17,alpha-hydroxypregn-4-ene-3,11,20-trione
21-Acetoxy-17.alpha.-hydroxy-3,11,20-triketopregnene-4
21-Acetoxy-17.alpha.-hydroxypregn-4-ene-3,11,20-trione
21-Acetoxy-4-pregnen-17alpha-ol-3,11,20-trione
29253-51-8
4-Pregnen-17.alpha.,21-diol-3,11,20-trione 21-acetate
4-Pregnene-17,alpha,21-diol-3,11,20-trione 21-acetate
4-Pregnene-17.alpha.,21-diol-3,11,20-trione 21-acetate
4-Pregnene-17alpha,21-diol-3,11,20-trione 21-acetate
50-04-4
883WKN7W8X
AB00384283_09
AB00384283-08
AB2000655
AC-6827
AC1L1L1N
AC1Q62MF
Acetate cortisone
Adreson
AK163492
AKOS005267225
AN-9606
ARONIS24358
Artriona
AS-13692
BCP08487
BDBM50455157
Biocort acetate
BRD-K86161929-001-13-3
C-21758
C08173
CAS-50-04-4
CC-25981
CCG-204366
CCRIS 3661
CHEBI:3897
CHEMBL1650
component of Neosone
Compound E acetate
Corlin
Cortadren
Cortelan
Cortilen
Cortisone (acetate)
Cortisone 21-acetate
Cortisone 21-acetate, >=99%
Cortisone 21-acetate, 98+%
Cortisone acetate (Cortone)
Cortisone acetate (JP17/USP)
Cortisone acetate [USAN:JAN]
Cortisone acetate [USP:JAN]
Cortisone acetate, European Pharmacopoeia (EP) Reference Standard
Cortisone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
Cortisone acetate, United States Pharmacopeia (USP) Reference Standard
Cortisone monoacetate
Cortisone-21-acetate
Cortisone, 21-acetate
Cortistab
Cortisyl
Cortisyl artriona
Cortogen acetate
Cortone acetate
Cortone acetate (TN)
CS-1742
CTK8D6790
D00973
DB01380
DSSTox_CID_2858
DSSTox_GSID_22858
DSSTox_RID_76761
DTXSID0022858
EINECS 200-006-5
EU-0100271
FT-0665176
HMS2235D24
HMS3259N19
HMS3260H04
HY-17461A
Incortin
Irisone acetate
ITRJWOMZKQRYTA-RFZYENFJSA-N
J10115
LMST02030120
Lopac0_000271
LP00271
LS-55003
MCULE-8390750975
MFCD00003609
MLS000069478
MLS002207136
MLS002548859
MolPort-002-507-122
NC00677
NCGC00021191-03
NCGC00021191-06
NCGC00021191-07
NCGC00021191-08
NCGC00021191-09
NCGC00260956-01
Neosone (Salt/Mix)
NSC 49420
NSC-49420
NSC49420
Pregn-4-ene-3,11,20-trione, 17,21-dihydroxy-, 21-acetate
Pregn-4-ene-3,11,20-trione, 21-(acetyloxy)-17-hydroxy-
Pregn-4-ene-3,20-trione, 17,21-dihydroxy-, 21-acetate
Pregn-4-ene-3,20-trione, 21-(acetyloxy)-17-hydroxy-
Ricortex
S2559
SBB080776
SCHEMBL4501
Scheroson
SMR000059124
ST075179
ST24046370
Tox21_113482
Tox21_113482_1
Tox21_500271
UNII-883WKN7W8X
W-105993
ZINC3875334

US Patents and Regulatory Information for cortisone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms CORTISONE ACETATE cortisone acetate TABLET;ORAL 080776-002 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial   Start Trial
Lannett CORTISONE ACETATE cortisone acetate TABLET;ORAL 080694-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Panray CORTISONE ACETATE cortisone acetate TABLET;ORAL 008284-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs CORTISONE ACETATE cortisone acetate TABLET;ORAL 009458-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CORTISONE ACETATE cortisone acetate TABLET;ORAL 008126-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Moodys
Mallinckrodt
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.